Rishi Gupta, Director at Verona Pharma plc (VRNA), sold 562,913 shares at $22.26 ($11.7M) on 2023-05-11, disclosed to the SEC on 2023-05-15.
Open-market sale of $11.7M VRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.26 | 80,000 | $1.8M | 15.2% |
| 2 | $22.26 | 80,000 | $1.8M | 15.2% |
| 3 | $21.64 | 43,200 | $935K | 8.0% |
| 4 | $20.00 | 345,313 | $6.9M | 58.9% |
| 5 | $21.96 | 14,400 | $316K | 2.7% |
| Total | $20.82 avg | 562,913 |
| $11.7M |
| 100% |
| Filing → |
| VRNA | SELL | 2022-12-27 | $200.7M | — | Filing → |
| DMTX | BUY | 2015-10-29 | $2.6M | — | Filing → |